Cargando…
Monocyte urokinase-type plasminogen activator up-regulation reduces thrombus size in a model of venous thrombosis
BACKGROUND: Our previous studies showed that the direct injection of an adenovirus construct expressing urokinase-type plasminogen activator (uPA) into experimental venous thrombi significantly reduces thrombus weight. The systemic use of adenovirus vectors is limited by inherent hepatic tropism and...
Autores principales: | Humphries, Julia, Gossage, James A., Modarai, Bijan, Burnand, Kevin G., Sisson, Thomas H., Murdoch, Colin, Smith, Alberto |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778796/ https://www.ncbi.nlm.nih.gov/pubmed/19703758 http://dx.doi.org/10.1016/j.jvs.2009.06.047 |
Ejemplares similares
-
Upregulation of hypoxia-inducible factor 1 alpha in local vein wall is associated with enhanced venous thrombus resolution
por: Evans, Colin E., et al.
Publicado: (2011) -
Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID‐19
por: Luo, Shengyuan, et al.
Publicado: (2022) -
Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis
por: Hindy, George, et al.
Publicado: (2022) -
Quantification of experimental venous thrombus resolution by longitudinal nanogold-enhanced micro-computed tomography
por: Grover, Steven P., et al.
Publicado: (2015) -
In silico docking of urokinase plasminogen activator and integrins
por: Degryse, Bernard, et al.
Publicado: (2008)